Common Contracts

2 similar null contracts

Contract
October 26th, 2021
  • Filed
    October 26th, 2021

CLINICAL TRIAL AGREEMENT SMLOUVA O KLINICKÉ STUDII For Protocol CC-10004-PPSO-004 pro protokol CC-10004-PPSO-004 This clinical trial agreement (hereinafter, the “Agreement”) is by and between: Tato smlouva o klinické studii (dále „smlouva”), byla uzavřena mezi těmito stranami: Amgen s.r.o having its principal office at Klimentská 1216/46, 110 02 Praha 1, Czech Republic. Company is registered under VAT number 27117804, tax exempt number CZ27117804 in the Commercial Register of the Municipal Court in Prague, Section C, Insert No. 97583; represented by xxx and xxx, duly empowered for the purposes hereof.(hereinafter the “Sponsor”) Amgen s.r.o. se sídlem Klimentská 1216/46, 110 02 Praha 1, Česká republika. Společnost je registrována s číslem IČO: 27117804, DIČ: CZ27117804 vobchodním rejstříku Městského soudu v Praze, oddíl C, vložka č. 97583; zastoupená xxx a xxx, řádně zmocněná pro účely tohoto dokumentu.(dále jen „zadavatel“) AND A Fakultní nemocnice Královské Vinohrady located at Šrobár

AutoNDA by SimpleDocs
Contract
September 4th, 2020
  • Filed
    September 4th, 2020

CLINICAL TRIAL AGREEMENT SMLOUVA O KLINICKÉ STUDII For Protocol FEDR-MF-002 pro protokol FEDR-MF-002 This clinical trial agreement (hereinafter, the “Agreement”) is by and between: Tuto smlouvu o klinické studii (dále „smlouva”) uzavřely tyto strany: Impact Biomedicines, Inc. a wholly owned Subsidiary of Celgene Corporation, having its principal office at 86 Morris Avenue, Summit, NJ 07901, USA (hereinafter called „Sponsor“) represented for the purposes of this Agreement by Celgene International II Sàrl, a limited liability company organized under the laws of Switzerland having its principal office at Rue du Pré-Jorat 14, 2108 Couvet, Switzerland and represented for the purposes of the signature of this Agreement by ICON Clinical Research Limited, South County Businesspark, Leopardstown, Dublin 18, Ireland, Tax ID No. IE 8201978R (hereinafter „the CRO“) Impact Biomedicines, Inc., dceřinná společnost Celgene Corporation s hlavním sídlem v 86 Morris Avenue, Summit, NJ 07901, USA (dále je

Time is Money Join Law Insider Premium to draft better contracts faster.